Carolinas Wealth Consulting’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $28.6K | Buy |
|
|||||
|
2024
Q4 | $22.6K | Hold |
|
|||||
|
2024
Q3 | $26K | Sell |
|
|||||
|
2024
Q2 | $26.7K | Sell |
|
|||||
|
2024
Q1 | $47.2K | Sell |
|
|||||
|
2023
Q4 | $106K | Buy |
|
|||||
|
2023
Q3 | $74.2K | Sell |
|
|||||
|
2023
Q2 | $108K | Buy |
|
|||||
|
2023
Q1 | $72.8K | Buy |
|
|||||
|
2022
Q4 | $48.2K | Sell |
|
|||||
|
2022
Q3 | $53K | Sell |
|
|||||
|
2022
Q2 | $57K | Sell |
|
|||||
|
2022
Q1 | $66K | Sell |
|
|||||
|
2021
Q4 | $68K | Hold |
|
|||||
|
2021
Q3 | $56K | Hold |
|
|||||
|
2021
Q2 | $63K | Hold |
|
|||||
|
2021
Q1 | $67K | Buy |
|
|||||
|
2020
Q4 | $63K | Buy |
|
|||||
|
2020
Q3 | $37K | Buy |
|
|||||
|
2020
Q2 | $23K | Buy |
|